title: [Chronic systolic heart failure. Optimized pharmacotherapy improves prognosis].
authors.affiliation: DRK-Krankenhaus Westerwald, 57627 Hachenburg. pdrstiefel@aol.com
authors.forename: Peter
authors.initials: P
authors.lastname: Stiefelhagen
mesh_terms: D000368:Aged; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002317:Cardiovascular Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002908:Chronic Disease; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use; D010593:Pharmaceutical Services; D011379:Prognosis; D012307:Risk Factors
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D002317:Cardiovascular Agents; D004071:Digitalis Glycosides; D004232:Diuretics; D000451:Mineralocorticoid Receptor Antagonists